Management of Diabetic Nephropathy in Older Patients: A Need for Flexible Guidelines

References

• . Chew H, Ghazali SS, Ismail M, Haniff J, Bujang MA. Age ≥ 60 years was an independent risk factor for diabetes-related complications despite good control of cardiovascular risk factors in patients with type 2 diabetes mellitus. Exp Gerontol. 2013;48(5):485–491
   PubMedGoogle Scholar
• . National Diabetes Fact Sheet. National Estimates and General Information on Diabetes and Prediabetes in the United States. Atlanta, GA: Centers for Disease Control and Prevention; 2011
   Google Scholar
• . Abi Khalil C, Roussel R, Mohammedi K, Danchin N, Marre M. Cause specific mortality in diabetes: recent changes in trend mortality. Eur J Prev Cardiol. 2012;19(3):374–381
   PubMedGoogle Scholar
• . Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DE. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr. 2010;8:29
   PubMed Web of Science ®Google Scholar
• . Narayan KM, Boyle JP, Geiss LS, Saaddine JB, Thompson TJ. Impact of recent increase in incidence on future diabetes burden: U.S., 2005–2050. Diabetes Care. 2006;29(9):2114–2116
   PubMed Web of Science ®Google Scholar
• . Hill CJ, Fogarty DG. Changing trends in end-stage renal disease due to diabetes in the United Kingdom. J Ren Care. 2012;38( Suppl 1):12–22
   PubMedGoogle Scholar
• . Raptis AE, Viberti G. Pathogenesis of diabetic nephropathy. Exp Clin Endocrinol Diabetes. 2001;109( Suppl 2):S424–S437
   PubMed Web of Science ®Google Scholar
• . Macisaac RJ, Jerums G. Diabetic kidney disease with and without albuminuria. Curr Opin Nephrol Hypertens. 2011;20(3):246–257
   PubMed Web of Science ®Google Scholar
• . Pham TT, Sim JJ, Kujubu DA, Liu IL, Kumar VA. Prevalence of nondiabetic renal disease in diabetic patients. Am J Nephrol. 2007;27(3):322–328
   PubMed Web of Science ®Google Scholar
• . National Kidney Foundation. KDOQI clinical practice guideline for diabetes and CKD: 2012 update. Am J Kidney Dis. 2012;60(5):850–886
   PubMed Web of Science ®Google Scholar
• . Abdelhafiz AH, Tan E, Levett C, Minchin J, Nahas ME. Natural history and predictors of faster glomerular filtration rate decline in a referred population of older patients with type 2 diabetes mellitus. Hosp Pract (1995). 2012;40(4):49–55
   PubMedGoogle Scholar
• . American Diabetes Association. Nephropathy in Diabetes. Diabetes Care. 2004;27:579–583
   Google Scholar
• . Robles NR, Felix FJ, Fernandez-Berges D, . Prevalence of abnormal urinary albumin excretion in elderly people: a Spanish survey. Int Urol Nephrol. 2013;45(2):553–560
   PubMedGoogle Scholar
• . O'Hare AM, Hailpern SM, Pavkov ME, . Prognostic implications of the urinary albumin to creatinine ratio in veterans of different ages with diabetes. Arch Intern Med. 2010;170(11):930–936
   PubMedGoogle Scholar
• . Barzilay JI, Fitzpatrick AL, Luchsinger J, Yasar S, Bernick C, Jenny NS, Kuller LH. Albuminuria and dementia in the elderly: a community study. Am J Kidney Dis. 2008;52(2):216–226
   PubMedGoogle Scholar
• . El Nahas M. Cardio-kidney-damage: a unifying concept. Kidney Int. 2010;78(1):14–18
   PubMed Web of Science ®Google Scholar
• . Vischer UM, Safar ME, Safar H, . Cardiometabolic determinants of mortality in a geriatric population: is there a “reverse metabolic syndrome”? Diabetes Metab. 2009;35(2):108–114
   PubMedGoogle Scholar
• . American Diabetes Association. Standards of medical care in diabetes-2013. Diabetes Care. 2013;36( Suppl 1):S11–S66
   PubMed Web of Science ®Google Scholar
• . Gerstein HC, Miller ME, Byington RP, ; Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358(24):2545–2559
   PubMed Web of Science ®Google Scholar
• . Currie CJ, Peters JR, Tynan A, . Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study. Lancet. 2010;375(9713):481–489
   PubMed Web of Science ®Google Scholar
• . Huang ES, Liu JY, Moffet HH, John PM, Karter AJ. Glycemic control, complications, and death in older diabetic patients: the diabetes and aging study. Diabetes Care. 2011;34(6):1329–1336
   PubMed Web of Science ®Google Scholar
• . Huang ES, Zhang Q, Gandra N, Chin MH, Meltzer DO. The effect of comorbid illness and functional status on the expected benefits of intensive glucose control in older patients with type 2 diabetes: a decision analysis. Ann Intern Med. 2008;149(1):11–19
   PubMed Web of Science ®Google Scholar
• . Centers for Disease Control and Prevention. Diabetes Public Health Resource. www.cdc.gov/diabetes. Accessed September 27, 2013
   Google Scholar
• . Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int Suppl. 2012;2:337–414
   Web of Science ®Google Scholar
• . Suissa S, Hutchinson T, Brophy JM, Kezouh A. ACE-inhibitor use and the long-term risk of renal failure in diabetes. Kidney Int. 2006;69(5):913–919
   PubMed Web of Science ®Google Scholar
• . Mann JF, Anderson C, Gao P, ; ONTARGET Investigators. Dual inhibition of the renin-angiotensin system in high-risk diabetes and risk for stroke and other outcomes: results of the ONTARGET trial. J Hypertens. 2013;31(2):414–421
   PubMedGoogle Scholar
• . Parving HH, Brenner BM, Mcurray JJ, ; ALTITUDE Investigators. Cardiorenal end points in a trial of aliskiren for type 2 diabetes. N Engl J Med. 2012;367(23):2204–2213
   PubMed Web of Science ®Google Scholar
• . Beckett NS, Peters R, Fletcher AE, ; HYVET Study Group. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358(18):1887–1898
   PubMed Web of Science ®Google Scholar
• . van Hateren KJ, Landman GW, Kleefstra N, Groenier KH, Kamper AM, Houweling ST, Bilo HJ. Lower blood pressure associated with higher mortality in elderly diabetic patients (ZODIAC-12). Age Ageing. 2010;39(5):603–609
   PubMedGoogle Scholar
• . Cushman WC, Evans GW, Byington RP, ; ACCORD Study Group. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362(17):1575–1585
   PubMed Web of Science ®Google Scholar
• . Cooper-DeHoff RM, Gong Y, Handberg EM, Bavry AA, Denardo SJ, Bakris GL, Pepine CJ. Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. JAMA. 2010;304(1):61–68
   PubMed Web of Science ®Google Scholar
• . Cederholm J, Gudbjörnsdottir S, Eliasson B, Zethelius B, Eeg-Olofsson K, Nilsson PM; NDR. Systolic blood pressure and risk of cardiovascular diseases in type 2 diabetes: an observational study from the Swedish national diabetes register. J Hypertens. 2010;28(10):2026–2035
   PubMedGoogle Scholar
• . Molander L, Lövheim H, Norman T, Nordström P, Gustafson Y. Lower systolic blood pressure is associated with greater mortality in people aged 85 and older. J Am Geriatr Soc. 2008;56(10):1853–1859
   PubMed Web of Science ®Google Scholar
• . Kidney Disease Outcomes Quality Initiative. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis. 2007;49(2 Suppl 2):S12–S154
   PubMed Web of Science ®Google Scholar
• . Heart Protection Study Collaborative Group. MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360(9326):7–22
   PubMed Web of Science ®Google Scholar
• . Baigent C, Keech A, Kearney PM, ; Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins [Errata in Lancet. 2005;366(9494):1358 and Lancet. 2008;371(9630):2084]. Lancet. 2005;366(9493):1267–1278
   PubMed Web of Science ®Google Scholar
• . Petersen LK, Christensen K, Kragstrup J. Lipid-lowering treatment to the end? A review of observational studies and RCTs on cholesterol and mortality in 80+-year olds. Age Ageing. 2010;39(6):674–680
   PubMedGoogle Scholar
• . Mielke MM, Zandi PP, Sjögren M, Gustafson D, Ostling S, Steen B, Skoog I. High total cholesterol levels in late life associated with a reduced risk of dementia. Neurology. 2005;64(10):1689–1695
   PubMed Web of Science ®Google Scholar
• . Solomon A, Kåreholt I, Ngandu BM, . Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study. Neurology. 2007;68:751–756
   PubMed Web of Science ®Google Scholar
• . Yudkin JS, Lipska KJ, Montori VM. The idolatry of the surrogate. BMJ. 2011;343:d7995
   PubMedGoogle Scholar
• . Ahmed AK, Kamath NS, El Kossi M, El Nahas AM. The impact of stopping inhibitors of the renin-angiotensin system in patients with advanced chronic kidney disease. Nephrol Dial Transplant. 2010;25(12):3977–3982
   PubMed Web of Science ®Google Scholar
• . Moen MF, Zhan M, Hsu VD, Walker LD, Einhorn LM, Seliger SL, Fink JC. Frequency of hypoglycemia and its significance in chronic kidney disease. Clin J Am Soc Nephrol. 2009;4(6):1121–1127
   PubMed Web of Science ®Google Scholar